van Wyk J, Ait-Khaled M, Santos J, Scholten S, et al. Improvement in Metabolic Health Parameters at Week 48 After Switching From a Tenofovir Alafenamide-Based 3- or 4-Drug Regimen to the 2-Drug Regimen of Dolutegravir/Lamivudine: The TANGO Study. J Acquir Immune Defic Syndr 2021 Feb 12. pii: 00126334-900000000-95934.
PMID: 33587500